About Biologics


Biologics (ISSN 2673-8449) provides an advanced forum for findings on all aspects of biologics derived from both novel and established biotechnologies. It publishes reviews, research papers, and communications in all areas of biologicals and at the interface of related disciplines. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the maximum length of the papers. Full experimental and/or methodical details must be provided so that the results can be reproduced. Electronic files or software regarding the full details of the calculation and experimental procedure – if impossible to publish in a normal way – can be deposited as supplementary material.

Subject Areas

This journal covers all topics related to biologics. Topics of interest include but are not limited to the following:


  • Bacterial vaccines
  • Viral vaccines
  • Tumor vaccines


  • Insulin
  • Glucagon
  • Growth hormone
  • Gonadotrophins

Cytokines and allied mediators

  • Interleukins and Interleukin-based products (Interleukin-2)
  • Interferons (Interferons-α, -β, -γ)
  • Tumor necrosis factors
  • Chemokinefamily
  • Hematopoietic growth factors (Erythropoietin, colony-stimulating factors)


  • Radiology
  • Nuclear medicine
  • Medical imaging
  • Endoscopy
  • Pathology
  • Biopsy
  • Molecular diagnostics
  • Medical screening
  • Biomarkers
  • Diagnostic microbiology and infectious disease
  • Point-of-care testing and devices

Gene therapies

  • Somatic gene therapies
  • Germline gene therapies


  • Living cells used in cell therapy
  • Cell culture technology
  • Cellular immunology


Thrombolytic agents (tissue plasminogen activator)

Monoclonal antibodies (Various)

Blood and blood components


Downstream processing

General bacteriology

General virology, endogenous, and adventitious viruses

Molecular biology


Prion and prion disease

Protein chemistry




  • Human
  • Animal
  • Plant
  • Fungus
  • Microorganism

MDPI Publication Ethics Statement

MDPI is a member of the Committee on Publication Ethics (COPE). MDPI takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, inappropriate authorship credit, and the like, do arise. MDPI takes such publishing ethics issues very seriously and our editors are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use iThenticate to check submissions against previous publications.

Book Reviews

Authors and publishers are encouraged to send review copies of their recent related books to the following address. Received books will be listed as Books Received within the journal's News & Announcements section.

St. Alban-Anlage 66
CH-4052 Basel

Copyright / Open Access

Articles published in Biologics will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). The copyright is retained by the author(s). MDPI will insert the following note at the end of the published text:

© 2023 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/).


Reprints may be ordered. Please contact for more information on how to order reprints.

Announcement and Advertisement

Announcements regarding academic activities such as conferences are published for free in the News & Announcements section of the journal. Advertisement can be either published or placed on the pertinent website. Contact e-mail address is .

Editorial Office

Contact us

For further MDPI contacts, see here.

Back to TopTop